Emergence of potential biomarkers of response to anti-angiogenic anti-tumour agents.
Tools
Tools
Tools
Michael, A, Relph, K and Pandha, H (2010) Emergence of potential biomarkers of response to anti-angiogenic anti-tumour agents. International Journal of Cancer, 127 (6). 1251 - 1258. ISSN 0020-7136
![[img]](/style/images/fileicons/application_pdf.png)
| PDF 32Kb | |
| PDF 255Kb | |
| PDF 14Kb | |
| PDF 106Kb | |
![[img]](/style/images/fileicons/application_msword.png) | Microsoft Word 94Kb | |
| Microsoft Word 32Kb | |
| Microsoft Word 1011Kb |
Official URL: http://dx.doi.org/10.1002/ijc.25389
Abstract
Anti-angiogenic agents targeting tumour vasculature have an established place in clinical practice, and new data are constantly emerging. However, despite rapid clinical uptake, a very large number of questions regarding these agents remain unanswered. One of the main hurdles in clinical practice is lack of accurate and feasible ways of assessing response to drug beyond tumour reduction on conventional imaging. This review summarises recent developments in the field of biomarkers of response to anti-VEGF drugs.
| Item Type: | Article |
|---|---|
| Additional Information: | The definitive version is available at <a href="http://onlinelibrary.wiley.com/doi/10.1002/ijc.25389/pdf"</a>. |
| Uncontrolled Keywords: | Angiogenesis Inhibitors, Antineoplastic Agents, Humans, Tumor Markers, Biological, Vascular Endothelial Growth Factor A |
| Divisions: | Faculty of Health and Medical Sciences > Microbial and Cellular Sciences |
| ID Code: | 209783 |
| Deposited By: | Symplectic Elements |
| Deposited On: | 15 May 2012 14:44 |
| Last Modified: | 16 Mar 2013 14:54 |
Document Downloads
Repository Staff Only: item control page